Alan B. Sandler

Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

Alan B. Sandler, John Nemunaitis, Claude Denham et al. · Journal of Clinical Oncology · 2000 · 718 citations

Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.

Michael B. Atkins, Michael J. Robertson, Michael S. Gordon et al. · PubMed · 1997 · 590 citations

Immunology, Pharmacotherapy, Immunotherapy +19

Randomized phase II/III trial of paclitaxel (P) plus carboplatin (C) with or without bevacizumab (NSC #704865) in patients with advanced non-squamous non-small cell lung cancer (NSCLC): An Eastern Cooperative Oncology Group (ECOG) Trial - E4599

Alan B. Sandler, R Gray, Julie R. Brahmer et al. · Journal of Clinical Oncology · 2005 · 360 citations

Immunology, Pathology, Lba4 Background +16

Outcomes for Elderly, Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel: Analysis of Eastern Cooperative Oncology Group Trial 4599

Suresh S. Ramalingam, Suzanne E. Dahlberg, Corey J. Langer et al. · Journal of Clinical Oncology · 2007 · 350 citations · Full text

Molecular Characteristics of Bronchioloalveolar Carcinoma and Adenocarcinoma, Bronchioloalveolar Carcinoma Subtype, Predict Response to Erlotinib

Vincent A. Miller, Gregory J. Riely, Maureen F. Zakowski et al. · Journal of Clinical Oncology · 2008 · 299 citations